BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30989466)

  • 1. Involvement of EP2 and EP4 Receptors in Eosinophilic Esophagitis: A Pilot Study.
    Durchschein F; Eherer A; Grill M; Sturm EM; Pommer V; Langner C; Högenauer C; Schicho R
    Dig Dis Sci; 2019 Oct; 64(10):2806-2814. PubMed ID: 30989466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors.
    Konya V; Philipose S; Bálint Z; Olschewski A; Marsche G; Sturm EM; Schicho R; Peskar BA; Schuligoi R; Heinemann A
    Eur J Immunol; 2011 Aug; 41(8):2379-89. PubMed ID: 21681739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
    Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus.
    Zhang S; Wu X; Yu S
    Dis Esophagus; 2014 Aug; 27(6):601-6. PubMed ID: 24165271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of PGE2 receptor subtypes in human eosinophils.
    Mita H; Hasegawa M; Higashi N; Akiyama K
    J Allergy Clin Immunol; 2002 Sep; 110(3):457-9. PubMed ID: 12209094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PGE
    Karaki SI; Tanaka R
    J Physiol Sci; 2021 Feb; 71(1):8. PubMed ID: 33622238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
    Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
    Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Ishikawa I
    J Periodontal Res; 1999 Nov; 34(8):478-85. PubMed ID: 10697805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 regulates interleukin-1beta-induced matrix metalloproteinase-3 production in human gingival fibroblasts.
    Ruwanpura SM; Noguchi K; Ishikawa I
    J Dent Res; 2004 Mar; 83(3):260-5. PubMed ID: 14981131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.
    Shin JM; Park IH; Moon YM; Hong SM; Cho JS; Um JY; Lee HM
    Am J Rhinol Allergy; 2014; 28(3):e120-4. PubMed ID: 24980222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EP2 and EP4 receptors mediate PGE2 induced relaxation in murine colonic circular muscle: pharmacological characterization.
    Martinez-Cutillas M; Mañé N; Gallego D; Jimenez M; Martin MT
    Pharmacol Res; 2014 Dec; 90():76-86. PubMed ID: 25461458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
    Zeng L; An S; Goetzl EJ
    J Biol Chem; 1996 Nov; 271(44):27744-50. PubMed ID: 8910368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves.
    Kopp UC; Cicha MZ; Nakamura K; Nüsing RM; Smith LA; Hökfelt T
    Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1269-82. PubMed ID: 15292051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons.
    Hayashi Y; Morinaga S; Liu X; Zhang J; Wu Z; Yokoyama T; Nakanishi H
    Mediators Inflamm; 2016; 2016():5079597. PubMed ID: 27298516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.
    Echeverria V; Clerman A; Doré S
    Eur J Neurosci; 2005 Nov; 22(9):2199-206. PubMed ID: 16262658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
    McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
    Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.